The best of R&I and around the web, handpicked by our editors.
White papers, service directory and conferences for the R&I community.
Web replica of the print magazine.
In part 4 of our 2024 drug trends series, we’re evaluating workers’ comp high impact drug class patterns and strategies to address the challenges these cost drivers are creating.
In part 3 of our 2023 drug trends series, we’re evaluating workers’ comp opioid patterns and the strategies being used to continue their decline in use and manage their risks.
In part two of our drug trends series, we look at trends from our combined prospectively and retrospectively managed network channels to address the total view of prescription activity.
Each year Enlyte releases its drug trends series to analyze the state of pharmacy trends in workers’ comp. In part one of our 2023 series, we’re evaluating retail and mail order prescriptions.
In part two of our 2023 drug trends series, we’re evaluating in-network and out-of-network prescription for a total view of prescription activity.
Each year Enlyte releases its annual drug trends series to analyze the state of pharmacy trends in workers’ comp. In part one of our 2023 series, we’re evaluating retail and mail order prescriptions.
Events of 2013 point the way forward next year. Buzz words: cyber, health care and property.
Newsletters
Risk Central
Risk Central
Digital Edition
